Allspring Global Investments’s Integra LifeSciences IART Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-4,662
Closed -$136K 2524
2024
Q2
$136K Buy
4,662
+1,711
+58% +$50.7K ﹤0.01% 1796
2024
Q1
$105K Sell
2,951
-41,363
-93% -$1.65M ﹤0.01% 1837
2023
Q4
$1.93M Sell
44,314
-26,513
-37% -$1.04M ﹤0.01% 1189
2023
Q3
$2.7M Buy
70,827
+57,993
+452% +$2.44M ﹤0.01% 1115
2023
Q2
$528K Buy
12,834
+1,809
+16% +$87.1K ﹤0.01% 1554
2023
Q1
$633K Sell
11,025
-333
-3% -$18.8K ﹤0.01% 1540
2022
Q4
$637K Buy
11,358
+5,306
+88% +$270K ﹤0.01% 1529
2022
Q3
$256K Buy
6,052
+1,173
+24% +$60.1K ﹤0.01% 1748
2022
Q2
$263K Sell
4,879
-45,782
-90% -$2.75M ﹤0.01% 1741
2022
Q1
$3.25M Sell
50,661
-2,981
-6% -$196K ﹤0.01% 1295
2021
Q4
$3.59M Buy
+53,642
New +$3.63M ﹤0.01% 1292

Other funds holding IART

Allspring Global Investments's IART Position: Q3 2024 in Review

Allspring Global Investments sold out of Integra LifeSciences (IART) in Q3 2024, closing a stake of 4,662 shares — an estimated $136K sold.

Allspring Global Investments first reported a position in IART in Q4 2021 and held it in 11 quarters. The position peaked at $3.59M in Q4 2021. 225 funds tracked by Wall St. Rank hold IART as of Q3 2024.

  • Allspring Global Investments reported no remaining Integra LifeSciences position as of Q3 2024 after selling out during the quarter.
  • Allspring Global Investments sold 4,662 Integra LifeSciences shares in Q3 2024, an estimated $136K.
  • Allspring Global Investments first reported a position in Integra LifeSciences in Q4 2021 and held it in 11 quarters.
  • Allspring Global Investments's Integra LifeSciences position peaked at $3.59M in Q4 2021.
  • 225 funds tracked by Wall St. Rank held Integra LifeSciences as of Q3 2024.

Based on Allspring Global Investments's 13F filing for Q3 2024, filed 18 Oct 2024.